405000 플라즈맵
기본 정보
- 섹터: KOSDAQ:제조
- 시가총액: 150억원 (2026-06-30 기준)
- 첫 등장: 2026-06-12 (누적 1일)
- 태그: 매크로/바이오헬스 · 의료기기 · 플라즈마 · 멸균기 · 임플란트 · 치과
- 네이버 금융: 🔗
기업개요
- 동사는 2015년 KAIST 물리학과 실험실 창업으로 설립된 바이오 플라즈마 기술 전문기업으로, 2022년에 코스닥시장에 상장하였음.
- 플라즈마 원천기술로 저온멸균 솔루션, 임플란트 재생활성 솔루션, 치주·근관치료기 등 3대 제품을 글로벌 시장에서 사업화하고 있음.
- 2021년 비미국 회사 최초 FDA 인증 및 2025년 세계 최초 CE MDR 인증으로 글로벌 시장 확대와 헬스케어 산업으로 사업 영역을 확장하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 5,160 | 4,520 | 🔵 -12.40% | — | ×10.9 | ⚫ 그외 | -1.2억 | -1.2 | +0.0 | +0.0 | +0.0 | -1.5 | +2.6 |
| 2026-08-13 | 4,750 | 5,160 | 🔴 +8.63% | — | ×1.2 | ⚫ 그외 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | -0.0 | +0.1 |
| 2026-08-12 | 4,695 | 4,750 | 🔴 +1.17% | — | ×0.1 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-08-11 | 4,895 | 4,695 | 🔵 -4.09% | — | ×0.4 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.5 | -0.3 |
| 2026-08-10 | 4,600 | 4,895 | 🔴 +6.41% | — | ×0.1 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | -0.1 |
| 2026-08-07 | 4,535 | 4,600 | 🔴 +1.43% | — | ×0.1 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-08-06 | 4,570 | 4,535 | 🔵 -0.77% | — | ×0.1 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.2 | -0.1 |
| 2026-08-05 | 4,650 | 4,570 | 🔵 -1.72% | — | ×0.1 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-08-04 | 4,260 | 4,650 | 🔴 +9.15% | — | ×0.1 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.2 | +0.0 |
| 2026-08-03 | 4,490 | 4,260 | 🔵 -5.12% | — | ×0.1 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-07-31 | 4,610 | 4,490 | 🔵 -2.60% | — | ×0.1 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | -0.1 |
| 2026-07-30 | 4,320 | 4,610 | 🔴 +6.71% | — | ×0.1 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-29 | 4,700 | 4,320 | 🔵 -8.09% | — | ×0.1 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-28 | 5,100 | 4,700 | 🔵 -7.84% | — | ×0.1 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | -0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-27 | 4,930 | 5,100 | 🔴 +3.45% | — | ×0.2 | ⚫ 그외 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | -0.2 | +0.2 |
| 2026-07-24 | 5,520 | 4,930 | 🔵 -10.69% | — | ×0.7 | 🔻 개인 | -1.2억 | -1.2 | +0.0 | +0.0 | +0.0 | +0.9 | +0.3 |
| 2026-07-23 | 4,625 | 5,520 | 🔴 +19.35% | — | ×2.6 | ⚫ 그외 | +0.4억 | +0.4 | +0.0 | +0.0 | +0.0 | -3.5 | +3.0 |
| 2026-07-22 | 5,010 | 4,625 | 🔵 -7.68% | — | ×2.9 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | -0.2 | +0.0 | +1.3 | -1.1 |
| 2026-07-21 | 3,860 | 5,010 | 🔴 +29.79% | — | ×11.7 | ⚫ 그외 | -0.2억 | -0.2 | +0.0 | +0.3 | +0.0 | -1.0 | +0.9 |
| 2026-07-20 | 3,485 | 3,860 | 🔴 +10.76% | — | ×42.0 | ⚫ 그외 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | -2.0 | +2.1 |
| 2026-07-16 | 3,295 | 3,485 | 🔴 +5.77% | — | ×1.2 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | +0.1 | -0.2 |
| 2026-07-15 | 3,455 | 3,295 | 🔵 -4.63% | — | ×0.9 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.1 | -0.1 |
| 2026-07-14 | 3,415 | 3,455 | 🔴 +1.17% | — | ×1.1 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 |
| 2026-07-13 | 3,560 | 3,415 | 🔵 -4.07% | — | ×1.7 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | -0.0 |
| 2026-07-10 | 3,720 | 3,560 | 🔵 -4.30% | — | ×0.2 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-09 | 3,715 | 3,720 | 🔴 +0.13% | — | ×0.8 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.3 | -0.1 |
| 2026-07-08 | 3,770 | 3,715 | 🔵 -1.46% | — | ×1.3 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | -0.0 | +0.0 | +0.4 | -0.2 |
| 2026-07-07 | 3,630 | 3,770 | 🔴 +3.86% | — | ×0.4 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-07-06 | 3,555 | 3,630 | 🔴 +2.11% | — | ×0.8 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-07-03 | 3,725 | 3,555 | 🔵 -4.56% | — | ×0.1 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | -0.0 | +0.0 | -0.0 | -0.0 |
| 2026-07-02 | 3,920 | 3,725 | 🔵 -4.97% | — | ×0.1 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-01 | 3,920 | 3,920 | ⚪ +0.00% | — | ×0.2 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-06-30 | 3,755 | 3,920 | 🔴 +4.39% | — | ×0.7 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-06-29 | 3,655 | 3,755 | 🔴 +2.74% | — | ×0.6 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | -0.0 |
| 2026-06-26 | 3,500 | 3,655 | 🔴 +4.43% | — | ×0.4 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | -0.0 | |
| 2026-06-25 | 3,845 | 3,500 | 🔵 -8.97% | — | ×0.8 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-06-24 | 3,615 | 3,845 | 🔴 +6.36% | — | ×0.7 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | -0.0 | |
| 2026-06-23 | 3,705 | 3,615 | 🔵 -2.43% | — | ×1.4 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | +0.0 | |
| 2026-06-22 | 3,935 | 3,705 | 🔵 -5.84% | — | ×0.7 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | +0.0 | |
| 2026-06-19 | 3,780 | 3,935 | 🔴 +4.10% | — | ×0.7 | ⚫ 그외 | +0.0억 | +0.0 | +0.0 | -0.0 | -0.0 | +0.0 | |
| 2026-06-18 | 4,155 | 3,780 | 🔵 -9.03% | — | ×2.2 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | -0.3 | +0.0 | |
| 2026-06-17 | 4,300 | 4,155 | 🔵 -3.37% | — | ×0.9 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | +0.0 | |
| 2026-06-16 | 4,350 | 4,300 | 🔵 -1.15% | — | ×0.9 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | -0.0 | +0.3 | +0.0 | |
| 2026-06-15 | 4,930 | 4,350 | 🔵 -11.76% | — | ×0.8 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | +0.0 | |
| 2026-06-12 | 4,420 | 4,930 | 🔴 +11.54% | — | ×0.9 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 | |
| 2026-06-11 | 4,200 | 4,420 | 🔴 +5.24% | — | ×0.3 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | |
| 2026-06-10 | 4,325 | 4,200 | 🔵 -2.89% | — | ×0.6 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | -0.0 | |
| 2026-06-09 | 4,650 | 4,325 | 🔵 -6.99% | — | ×1.3 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-06-08 | 4,960 | 4,650 | 🔵 -6.25% | — | ×0.3 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 | |
| 2026-06-05 | 5,390 | 4,960 | 🔵 -7.98% | — | ×1.1 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | |
| 2026-06-04 | 5,610 | 5,390 | 🔵 -3.92% | — | ×1.9 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | -0.0 | |
| 2026-06-02 | 6,560 | 5,610 | 🔵 -14.48% | — | ×2.9 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.3 | -0.1 | |
| 2026-06-01 | 5,230 | 6,560 | 🔴 +25.43% | — | ×4.7 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | +0.0 | -0.8 | +0.1 | |
| 2026-05-29 | 5,380 | 5,230 | 🔵 -2.79% | — | ×1.0 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | +0.0 |
일자별 사유 (최신 위)
2026-07-23
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +583억)
- 매크로 원인: 코스피·코스닥 급등장 속 개별 임상·M&A·주주환원 모멘텀이 겹치며 제약바이오 전반 강세 (보통)
2026-07-21
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart -1,686억)
- 매크로 원인: 코스피 3.56% 반등 속 바이오·헬스 개별 호재·상폐위기 저가주 반등이 혼재 (보통)
2026-07-20
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart -1,051억)
- 매크로 원인: 삼천당제약 경구용 세마글루타이드 FDA 답변서 수령 소식에 개별 바이오 급등 (보통)
2026-06-12
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +3,896억)
- 매크로 원인: 의료AI(제이엘케이·뷰노) 신의료기술 진입·AI탑재 호재 주도, CRO·유전체·마이크로바이옴 개별 테마 혼재 (보통)